The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions

Briefings in Bioinformatics
Santiago Vilar, George Hripcsak

Abstract

Explosion of the availability of big data sources along with the development in computational methods provides a useful framework to study drugs' actions, such as interactions with pharmacological targets and off-targets. Databases related to protein interactions, adverse effects and genomic profiles are available to be used for the construction of computational models. In this article, we focus on the description of biological profiles for drugs that can be used as a system to compare similarity and create methods to predict and analyze drugs' actions. We highlight profiles constructed with different biological data, such as target-protein interactions, gene expression measurements, adverse effects and disease profiles. We focus on the discovery of new targets or pathways for drugs already in the pharmaceutical market, also called drug repurposing, in the interaction with off-targets responsible for adverse reactions and in drug-drug interaction analysis. The current and future applications, strengths and challenges facing all these methods are also discussed. Biological profiles or signatures are an important source of data generation to deeply analyze biological actions with important implications in drug-related studies.

References

Mar 10, 1999·JAMA : the Journal of the American Medical Association·T Brewer, G A Colditz
Aug 10, 2000·Cell·T R HughesS H Friend
Nov 28, 2001·Molecular Pharmacology·R S ThomasC A Bradfield
May 16, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kevin T Morgan
May 16, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hisham K HamadehCynthia A Afshari
Jul 18, 2002·Nature Reviews. Drug Discovery·Dan M Roden, Alfred L George
Aug 22, 2002·Toxicologic Pathology·Hisham K HamadehRichard S Paules
Nov 26, 2002·Journal of Chemical Information and Computer Sciences·Joseph L DurantJames G Nourse
Mar 5, 2003·Expert Opinion on Pharmacotherapy·Sophie GautierJacques Caron
Mar 23, 2004·Environmental Health Perspectives·Rupesh P AminCynthia A Afshari
Jun 16, 2004·Journal of Biomedical Informatics·Donald Gardner
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Aug 6, 2004·The New England Journal of Medicine·Amy HollemanWilliam E Evans
Nov 10, 2004·Organic & Biomolecular Chemistry·Andreas Bender, Robert C Glen
Dec 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anton F FliriRobert A Volkmann
Dec 24, 2005·Nature Chemical Biology·Anton F FliriRobert A Volkmann
Mar 9, 2006·Health Affairs·Christopher P Adams, Van V Brantner
Aug 31, 2006·Methods in Enzymology·Tanya Barrett, Ron Edgar
Nov 14, 2006·Nucleic Acids Research·Tanya BarrettRon Edgar
Nov 23, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M D LeeL Gong
Dec 13, 2006·Pharmacoepidemiology and Drug Safety·Matthijs L BeckerBruno H Ch Stricker
Dec 23, 2006·Nature Reviews. Cancer·Justin Lamb
Jan 24, 2007·Journal of Chemical Information and Modeling·Gilles Marcou, Didier Rognan
Feb 9, 2007·Nature Biotechnology·Michael J KeiserBrian K Shoichet
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maguy Del RioMarc Ychou
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Donald F Klein, Charles P O'Brien
Aug 10, 2007·Nature·Curtis R Chong, David J Sullivan
May 24, 2008·Nucleic Acids Research·Mathias DunkelRobert Preissner
Jul 16, 2008·Science·Monica CampillosPeer Bork
Jul 24, 2008·PloS One·Ausra MilanoMichael L Whitfield
Feb 3, 2009·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Francesco IorioDiego di Bernardo
Apr 15, 2009·Journal of Chemical Information and Modeling·Violeta I Pérez-NuenoJordi Teixidó
Apr 22, 2009·Journal of Medicinal Chemistry·Josef ScheiberJohn W Davies
Jul 3, 2009·Clinical Pharmacology and Therapeutics·A P Chiang, A J Butte

❮ Previous
Next ❯

Citations

Mar 13, 2017·Arthritis Research & Therapy·Daniel Toro-DomínguezMarta E Alarcón-Riquelme
Feb 13, 2020·Frontiers in Pharmacology·Huiqing WangZhiliang Yan
Apr 28, 2020·Journal of Medicinal Chemistry·Maurizio Recanatini, Chiara Cabrelle
Aug 9, 2019·Current Medicinal Chemistry·Chen Wang, Lukasz Kurgan
May 21, 2021·Frontiers in Genetics·Jianlin WangGe Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.